PHARMATECA » Search Articles by Keyword

Found: 35 articles

Article	Edition
A.Yu. Kochish, S.N. Ivanov CASE OF OSTEONECROSIS OF THE MAXILLA IN PATIENT WITH POSTMENOPAUSAL OSTEOPOROSIS AGAINST THE BACKGROUND OF PROLONGED TREATMENT WITH ANTIRESORPTIVE DRUGS	№5 / 2015
A.Yu.Kochish, MD, S.N. Ivanov COMPARATIVE EVALUATION OF THE EFFECTIVENESS OF DOMESTIC GENERICS AND ORIGINAL DRUG OF ZOLEDRONIC ACID IN PATIENTS WITH LOW-ENERGY VERTEBRAL FRACTURES AND POSTMENOPAUSAL OSTEOPOROSIS	№s5-14 / 2014
E.V. Biryukova POTENTIALS FOR THE USE OF ZOLENDRONATE IN THE TREATMENT OF OSTEOPOROSIS	№s5-14 / 2014
N.N. Semenov BONDRONAT – THE EXPERIENCE OF USE IN PATIENTS WITH BONE METASTASIS FROM BREAST CANCER	№8 / 2014
I.A. Kurnikova FOROSA IN THE THERAPY OF CALCIUM AND PHOSPHORUS METABOLISM DISORDERS IN ENDOCRINOLOGICAL PATIENTS	№5 / 2014
N.A. Shostak, A.A. Kondrashov, A.A. Muradyants, V.S. Shemenkova OSTEOPOROSIS IN MEN: APPROACHES TO THERAPY FROM THE PERSPECTIVE OF CURRENT POSITION	№s5-13 / 2013
E.V. Biryukova DO WE KNOW EVERYTHING ABOUT TREATMENT OF STEROID-INDUCED OSTEOPOROSIS?	№s5-13 / 2013
I.A. Baranova OSTEOPOROSIS IN PRACTICE OF PULMONOLOGIST	№s5-13 / 2013
N.N. Semenov THE USE OF BISPHOSPHONATES FOR THE PREVENTION OF BONE METASTASES IN BREAST CANCER PATIENTS	№8 / 2013
O.B. Ershova, A.V. Nazarova BISPHOSPHONATES - DURATION OF USE IN OSTEOPOROSIS, REASONABILITY AND SAFETY	№7 / 2013
S.G. Anikin, N.V. Toroptsova Bisphosphonates: What We Know About Adverse Events Associated With Their Use	№19 / 2012
I.I .Zubkov, Yu.A. Safonova, E.G. Zotkin Risedronate In The Treatment Of Osteoporosis: Efficacy And Tolerability	№16 / 2012